AGIO

#1984
Agios Pharmaceuticals, Inc.
33.3900 USD
+0.27%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
33.2950
33.4300
Rango anual
22.2400
45.9900
Cambio diario
+0.27%
Variación mensual
+20.50%
Variación en los últimos 6 meses
-23.05%
Cambio anual
-23.05%
Cierres anteriores
33.3000
Abrir
33.3850
Bid
Ask
Mínimo
33.2950
High
33.4300
Volumen
41
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Noticias